Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jostra AG

This article was originally published in The Gray Sheet

Executive Summary

Integration of cardiac surgery device supplier LifeStream International's "main" fields of business into Jostra AG's Jostra-Bentley unit following acquisition March 4 will allow LifeStream operations to continue out of Houston, the firm says. LifeStream's line of tubing sets for open-heart surgery, oxygenators, blood pumps, reservoirs and arterial filters will be combined with Hirrlingen, Germany-based Jostra offerings such as heart-lung machines, oxygenators, catheters and cannulae. The purchase furthers Jostra's strategy to establish a presence in the U.S. following its July 2000 acquisition of Bentley profusion products from Edwards Lifesciences. Privately held LifeStream has 300 employees and was formed in 1999 through the combination of C.R. Bard's cardiopulmonary division, oxygenator and cardioplegia systems sold by Minntech and Surgimedics (1"The Gray Sheet" July 19, 1999, p. 4)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT016220

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel